BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 18832571)

  • 1. Specific mutations in the beta-catenin gene (CTNNB1) correlate with local recurrence in sporadic desmoid tumors.
    Lazar AJ; Tuvin D; Hajibashi S; Habeeb S; Bolshakov S; Mayordomo-Aranda E; Warneke CL; Lopez-Terrada D; Pollock RE; Lev D
    Am J Pathol; 2008 Nov; 173(5):1518-27. PubMed ID: 18832571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis.
    Huss S; Nehles J; Binot E; Wardelmann E; Mittler J; Kleine MA; Künstlinger H; Hartmann W; Hohenberger P; Merkelbach-Bruse S; Buettner R; Schildhaus HU
    Histopathology; 2013 Jan; 62(2):294-304. PubMed ID: 23020601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
    Colombo C; Miceli R; Lazar AJ; Perrone F; Pollock RE; Le Cesne A; Hartgrink HH; Cleton-Jansen AM; Domont J; Bovée JV; Bonvalot S; Lev D; Gronchi A
    Cancer; 2013 Oct; 119(20):3696-702. PubMed ID: 23913621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
    Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
    Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Catenin mutation status and outcomes in sporadic desmoid tumors.
    Mullen JT; DeLaney TF; Rosenberg AE; Le L; Iafrate AJ; Kobayashi W; Szymonifka J; Yeap BY; Chen YL; Harmon DC; Choy E; Yoon SS; Raskin KA; Hornicek FJ; Nielsen GP
    Oncologist; 2013; 18(9):1043-9. PubMed ID: 23960186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm.
    Wang WL; Nero C; Pappo A; Lev D; Lazar AJ; López-Terrada D
    Pediatr Dev Pathol; 2012; 15(5):361-7. PubMed ID: 22372443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours.
    Kattentidt Mouravieva AA; Geurts-Giele IR; de Krijger RR; van Noesel MM; van de Ven CP; van den Ouweland AM; Kromosoeto JN; Dinjens WN; Dubbink HJ; Smits R; Wagner A
    Eur J Cancer; 2012 Aug; 48(12):1867-74. PubMed ID: 22305464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization by array comparative genomic hybridization and DNA sequencing of 194 desmoid tumors.
    Salas S; Chibon F; Noguchi T; Terrier P; Ranchere-Vince D; Lagarde P; Benard J; Forget S; Blanchard C; Dômont J; Bonvalot S; Guillou L; Leroux A; Mechine-Neuville A; Schöffski P; Laë M; Collin F; Verola O; Carbonnelle A; Vescovo L; Bui B; Brouste V; Sobol H; Aurias A; Coindre JM
    Genes Chromosomes Cancer; 2010 Jun; 49(6):560-8. PubMed ID: 20232483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of CTNNB1 gene mutation in primary sporadic aggressive fibromatosis.
    van Broekhoven DL; Verhoef C; Grünhagen DJ; van Gorp JM; den Bakker MA; Hinrichs JW; de Voijs CM; van Dalen T
    Ann Surg Oncol; 2015 May; 22(5):1464-70. PubMed ID: 25341748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Difficult to diagnose' desmoid tumours: a potential role for CTNNB1 mutational analysis.
    Colombo C; Bolshakov S; Hajibashi S; Lopez-Terrada L; Wang WL; Rao P; Benjamin RS; Lazar AJ; Lev D
    Histopathology; 2011 Aug; 59(2):336-40. PubMed ID: 21884214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced Sarcomas Occurring in Desmoid-type Fibromatosis Are Not Always Derived From the Primary Tumor.
    Verschoor AJ; Cleton-Jansen AM; Wijers-Koster P; Coffin CM; Lazar AJ; Nout RA; Rubin BP; Gelderblom H; Bovée JV
    Am J Surg Pathol; 2015 Dec; 39(12):1701-7. PubMed ID: 26414222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case.
    Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U
    Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near universal detection of alterations in CTNNB1 and Wnt pathway regulators in desmoid-type fibromatosis by whole-exome sequencing and genomic analysis.
    Crago AM; Chmielecki J; Rosenberg M; O'Connor R; Byrne C; Wilder FG; Thorn K; Agius P; Kuk D; Socci ND; Qin LX; Meyerson M; Hameed M; Singer S
    Genes Chromosomes Cancer; 2015 Oct; 54(10):606-15. PubMed ID: 26171757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CTNNB1 mutation analysis is a useful tool for the diagnosis of desmoid tumors: a study of 260 desmoid tumors and 191 potential morphologic mimics.
    Le Guellec S; Soubeyran I; Rochaix P; Filleron T; Neuville A; Hostein I; Coindre JM
    Mod Pathol; 2012 Dec; 25(12):1551-8. PubMed ID: 22766794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTNNB1 S45F mutation predicts poor efficacy of meloxicam treatment for desmoid tumors: a pilot study.
    Hamada S; Futamura N; Ikuta K; Urakawa H; Kozawa E; Ishiguro N; Nishida Y
    PLoS One; 2014; 9(5):e96391. PubMed ID: 24788118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
    Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
    Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
    Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased midkine expression correlates with desmoid tumour recurrence: a potential biomarker and therapeutic target.
    Colombo C; Creighton CJ; Ghadimi MP; Bolshakov S; Warneke CL; Zhang Y; Lusby K; Zhu S; Lazar AJ; West RB; van de Rijn M; Lev D
    J Pathol; 2011 Dec; 225(4):574-82. PubMed ID: 21826666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraabdominal sporadic desmoid tumors and inflammation: an updated literature review and presentation and insights on pathogenesis of synchronous sporadic mesenteric desmoid tumors occurring after surgery for necrotizing pancreatitis.
    Prete F; Rotelli M; Stella A; Calculli G; Sgaramella LI; Amati A; Resta N; Testini M; Gurrado A
    Clin Exp Med; 2023 Jul; 23(3):607-617. PubMed ID: 35913675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatio-temporal genetic heterogeneity of CTNNB1 mutations in sporadic desmoid type fibromatosis lesions.
    Doyen J; Duranton-Tanneur V; Hostein I; Karanian-Philippe M; Chevreau C; Breibach F; Coutts M; Dadone B; Saint-Paul MC; Gugenheim J; Duffaud F; Pedeutour F
    Virchows Arch; 2016 Mar; 468(3):369-74. PubMed ID: 26666421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.